Evidence map›Paper›PMID 42608389›Full record

ArticleCell discovery2026

Asymmetric RBBP7 regulates the first cell fate decision of early mammalian embryos.

Lin-Fang Ju, Xiao Han, Danru Zhang, Heng-Ji Xu, Shaokang Jia, Meng-Xia Liu, Yanchen Liu, Yu-Ting Cai, Yu-Sheng Chen, Chun-Chun Gao and 8 more

Abstract read
In one paragraph

Article in Cell discovery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Lin-Fang Ju *Beijing Key Laboratory of Intelligent Governance and Application of Biological Big Data, China National Center for Bioinformation, Beijing, China.ORCID http://orcid.org/0000-0002-0845-4301
Xiao Han *Beijing Key Laboratory of Intelligent Governance and Application of Biological Big Data, China National Center for Bioinformation, Beijing, China.
Danru Zhang *Beijing Key Laboratory of Intelligent Governance and Application of Biological Big Data, China National Center for Bioinformation, Beijing, China.
Heng-Ji Xu *Beijing Key Laboratory of Intelligent Governance and Application of Biological Big Data, China National Center for Bioinformation, Beijing, China.
Shaokang Jia *Key Laboratory of Biomedical Polymers of Ministry of Education, College of Chemistry and Molecular Sciences, Wuhan University, Wuhan, Hubei, China.
Meng-Xia LiuBeijing Key Laboratory of Intelligent Governance and Application of Biological Big Data, China National Center for Bioinformation, Beijing, China.
Yanchen LiuBeijing Key Laboratory of Intelligent Governance and Application of Biological Big Data, China National Center for Bioinformation, Beijing, China.
Yu-Ting CaiBeijing Key Laboratory of Intelligent Governance and Application of Biological Big Data, China National Center for Bioinformation, Beijing, China.
Yu-Sheng ChenBeijing Key Laboratory of Intelligent Governance and Application of Biological Big Data, China National Center for Bioinformation, Beijing, China.ORCID http://orcid.org/0000-0001-5292-1301
Chun-Chun GaoBeijing Key Laboratory of Intelligent Governance and Application of Biological Big Data, China National Center for Bioinformation, Beijing, China.ORCID http://orcid.org/0000-0002-5591-1034
Yong-Liang ZhaoBeijing Key Laboratory of Intelligent Governance and Application of Biological Big Data, China National Center for Bioinformation, Beijing, China.ORCID http://orcid.org/0000-0003-0121-1312
Yajing HaoBeijing Key Laboratory of Intelligent Governance and Application of Biological Big Data, China National Center for Bioinformation, Beijing, China.ORCID http://orcid.org/0000-0003-1384-4176
Xiu-Jie WangUniversity of Chinese Academy of Sciences, Beijing, China.ORCID http://orcid.org/0000-0001-7865-0204
Dangsheng LiState Key Laboratory of Molecular Biology, State Key Laboratory of Cell Biology, Shanghai Key Laboratory of Molecular Andrology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, China.
Xiang ZhouKey Laboratory of Biomedical Polymers of Ministry of Education, College of Chemistry and Molecular Sciences, Wuhan University, Wuhan, Hubei, China. xzhou@whu.edu.cn.
Ying YangBeijing Key Laboratory of Intelligent Governance and Application of Biological Big Data, China National Center for Bioinformation, Beijing, China. yingyang@cncb.ac.cn.ORCID http://orcid.org/0000-0002-8104-5985
Jianyong HanState Key Laboratory of Animal Biotech Breeding, College of Biological Sciences, China Agricultural University, Beijing, China. hanjy@cau.edu.cn.ORCID http://orcid.org/0000-0002-9549-3279
Yun-Gui YangBeijing Key Laboratory of Intelligent Governance and Application of Biological Big Data, China National Center for Bioinformation, Beijing, China. ygyang@cncb.ac.cn.ORCID http://orcid.org/0000-0002-2821-8541

Funding

China Postdoctoral Science Foundation 2024M753151National Natural Science Foundation of China (National Science Foundation of China) 92153303
6 · The paper itself

Abstract

Asymmetric transcription of noncoding RNA LincGET is currently recognized as the earliest event regulating the first cell fate decision in mammalian embryogenesis. However, whether key protein factors modulate this process remains elusive. Here, we identify RBBP7 as the earliest protein factor regulating developmental cell fate in mammals. Loss of RBBP7 drives cells towards ICM lineage. In mouse late 2-cell embryos, unequal translation of Rbbp7 contributes to its asymmetric protein distribution, which subsequently induces inversed asymmetric histone acetylation H3K9ac by interaction with HDAC1, thereby promoting cell differentiation. Interestingly, RBBP7 and LincGET exhibit a consistent asymmetric tendency but direct different cell fates; depletion or overexpression of both Rbbp7 and LincGET restored the cell fate bias, suggesting a coordinated regulatory mechanism during initial lineage specification. In summary, our study reveals RBBP7 as a new protein factor and elucidates its role in the first cell fate decision.

Identifiers

PMID42608389
PMCPMC13482399

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.